S&P 500   3,998.84 (-1.79%)
DOW   33,947.10 (-1.40%)
QQQ   287.64 (-1.68%)
AAPL   146.63 (-0.80%)
MSFT   250.20 (-1.89%)
META   122.43 (-0.86%)
GOOGL   99.48 (-0.96%)
AMZN   91.01 (-3.31%)
TSLA   182.45 (-6.37%)
NVDA   166.10 (-1.58%)
NIO   12.80 (-2.51%)
BABA   90.52 (+0.51%)
AMD   73.62 (-1.81%)
T   18.75 (-1.42%)
MU   54.04 (-1.17%)
CGC   4.32 (+0.70%)
F   13.38 (-3.46%)
GE   84.66 (-2.56%)
DIS   95.93 (-3.52%)
AMC   7.45 (-8.81%)
PYPL   73.62 (-1.39%)
PFE   50.73 (-0.35%)
NFLX   312.59 (-2.44%)
S&P 500   3,998.84 (-1.79%)
DOW   33,947.10 (-1.40%)
QQQ   287.64 (-1.68%)
AAPL   146.63 (-0.80%)
MSFT   250.20 (-1.89%)
META   122.43 (-0.86%)
GOOGL   99.48 (-0.96%)
AMZN   91.01 (-3.31%)
TSLA   182.45 (-6.37%)
NVDA   166.10 (-1.58%)
NIO   12.80 (-2.51%)
BABA   90.52 (+0.51%)
AMD   73.62 (-1.81%)
T   18.75 (-1.42%)
MU   54.04 (-1.17%)
CGC   4.32 (+0.70%)
F   13.38 (-3.46%)
GE   84.66 (-2.56%)
DIS   95.93 (-3.52%)
AMC   7.45 (-8.81%)
PYPL   73.62 (-1.39%)
PFE   50.73 (-0.35%)
NFLX   312.59 (-2.44%)
S&P 500   3,998.84 (-1.79%)
DOW   33,947.10 (-1.40%)
QQQ   287.64 (-1.68%)
AAPL   146.63 (-0.80%)
MSFT   250.20 (-1.89%)
META   122.43 (-0.86%)
GOOGL   99.48 (-0.96%)
AMZN   91.01 (-3.31%)
TSLA   182.45 (-6.37%)
NVDA   166.10 (-1.58%)
NIO   12.80 (-2.51%)
BABA   90.52 (+0.51%)
AMD   73.62 (-1.81%)
T   18.75 (-1.42%)
MU   54.04 (-1.17%)
CGC   4.32 (+0.70%)
F   13.38 (-3.46%)
GE   84.66 (-2.56%)
DIS   95.93 (-3.52%)
AMC   7.45 (-8.81%)
PYPL   73.62 (-1.39%)
PFE   50.73 (-0.35%)
NFLX   312.59 (-2.44%)
S&P 500   3,998.84 (-1.79%)
DOW   33,947.10 (-1.40%)
QQQ   287.64 (-1.68%)
AAPL   146.63 (-0.80%)
MSFT   250.20 (-1.89%)
META   122.43 (-0.86%)
GOOGL   99.48 (-0.96%)
AMZN   91.01 (-3.31%)
TSLA   182.45 (-6.37%)
NVDA   166.10 (-1.58%)
NIO   12.80 (-2.51%)
BABA   90.52 (+0.51%)
AMD   73.62 (-1.81%)
T   18.75 (-1.42%)
MU   54.04 (-1.17%)
CGC   4.32 (+0.70%)
F   13.38 (-3.46%)
GE   84.66 (-2.56%)
DIS   95.93 (-3.52%)
AMC   7.45 (-8.81%)
PYPL   73.62 (-1.39%)
PFE   50.73 (-0.35%)
NFLX   312.59 (-2.44%)
NASDAQ:IRTC

iRhythm Technologies - IRTC Stock Forecast, Price & News

$102.75
-8.15 (-7.35%)
(As of 12/5/2022 04:20 PM ET)
Add
Compare
Today's Range
$100.29
▼
$110.49
50-Day Range
$96.11
▼
$136.77
52-Week Range
$87.77
▼
$169.54
Volume
442,747 shs
Average Volume
397,595 shs
Market Capitalization
$3.09 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$158.36

iRhythm Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
57.2% Upside
$158.36 Price Target
Short Interest
Healthy
4.45% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.03mentions of iRhythm Technologies in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$2.19 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.82) to ($2.63) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.51 out of 5 stars

Medical Sector

136th out of 1,033 stocks

Surgical & Medical Instruments Industry

16th out of 104 stocks

See Top Rated MarketRank™ Stocks Here
IRTC stock logo

About iRhythm Technologies (NASDAQ:IRTC) Stock

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Stock News Headlines

December 1, 2022 | finance.yahoo.com
iRhythm Technologies' (NASDAQ:IRTC) growing losses don't faze investors as the stock advances 3.4% this past week
November 26, 2022 | americanbankingnews.com
William Blair Equities Analysts Decrease Earnings Estimates for iRhythm Technologies, Inc. (NASDAQ:IRTC)
December 5, 2022 | Investing Trends (Ad)
The Lithium "Lie"
Did you know each electric car battery requires 220 pounds of graphite – more than lithium, copper, or aluminum? China controls more than 90% of this vital ingredient. But the U.S. just classified graphite as "essential for America's National Defense"... and one little-known company is looking to win big in the energy war with China.
November 18, 2022 | seekingalpha.com
iRhythm: Revenue Upside Less Visible After Q3 Challenges
November 14, 2022 | finance.yahoo.com
Should You Consider iRhythm Technologies (IRTC) Shares for Investment?
November 8, 2022 | finance.yahoo.com
Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22
November 4, 2022 | finance.yahoo.com
Calculating The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)
November 2, 2022 | finance.yahoo.com
iRhythm Posts Smaller Than Expected Loss In Q3, But Shares Fall On Lowered Annual Guidance
December 5, 2022 | Investing Trends (Ad)
Are Investors Returning to the Small-Cap Uranium Sector?
Back in the early 2000's, small-cap Paladin Energy was the darling of the last uranium boom when it shot up from ten cents to over nine dollars. Today's uranium supply/demand imbalance has a lot in common with the last market cycle. Combined with the energy crisis and "green revolution," this could be setting the stage for the next uranium boom.
November 2, 2022 | finance.yahoo.com
iRhythm® Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
November 2, 2022 | finance.yahoo.com
iRhythm® Technologies Comments on the Final Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
November 1, 2022 | msn.com
IRhythm Technologies (IRTC) Reports Q3 Loss, Misses Revenue Estimates
November 1, 2022 | finance.yahoo.com
iRhythm Technologies Announces Third Quarter 2022 Financial Results
October 20, 2022 | finance.yahoo.com
iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022
October 11, 2022 | markets.businessinsider.com
What 5 Analyst Ratings Have To Say About iRhythm Technologies
October 6, 2022 | nasdaq.com
The five-year returns have been strong for iRhythm Technologies (NASDAQ:IRTC) shareholders despite underlying losses increasing
October 4, 2022 | nasdaq.com
IRTC Makes Bullish Cross Above Critical Moving Average
September 26, 2022 | 247wallst.com
iRythm’s Stock Slides -21% as Investor Day and Future Targets Disappoint
September 24, 2022 | seekingalpha.com
IRTC iRhythm Technologies, Inc.
September 21, 2022 | marketwatch.com
iRhythm Technologies Shares Tumble 11% Following Investor Day Outlook
September 4, 2022 | finance.yahoo.com
iRhythm Technologies, Inc. (IRTC)
September 2, 2022 | markets.businessinsider.com
6 Analysts Have This to Say About iRhythm Technologies
September 2, 2022 | seekingalpha.com
iRhythm: Fairly Priced At Current Multiples, No Need To Size Up
August 31, 2022 | finance.yahoo.com
iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022
August 18, 2022 | seekingalpha.com
iRhythm Technologies (IRTC) Investor Presentation - Slideshow
August 11, 2022 | nasdaq.com
Notable Thursday Option Activity: IRTC, BNGO, COST
August 6, 2022 | seekingalpha.com
iRhythm Technologies, Inc. (IRTC) CEO Quentin Blackford on Q2 2022 Results - Earnings Call Transcript
See More Headlines
Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Company Calendar

Last Earnings
11/01/2022
Today
12/05/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/22/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRTC
CUSIP
N/A
CIK
1388658
Web
www.irhythmtech.com
Phone
(415) 632-5700
Fax
N/A
Employees
1,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$158.36
High Stock Price Forecast
$198.00
Low Stock Price Forecast
$105.00
Forecasted Upside/Downside
+54.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($4.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-101,360,000.00
Net Margins
-33.79%
Pretax Margin
-33.72%
Return on Equity
-39.31%
Return on Assets
-22.42%

Debt

Debt-to-Equity Ratio
0.15
Current Ratio
3.42
Quick Ratio
3.25

Sales & Book Value

Annual Sales
$322.83 million
Price / Sales
9.58
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.50 per share
Price / Book
10.82

Miscellaneous

Outstanding Shares
30,111,000
Free Float
29,617,000
Market Cap
$3.09 billion
Optionable
Optionable
Beta
1.41

Key Executives

  • Mr. Quentin S. Blackford (Age 43)
    Pres, CEO & Director
    Comp: $671.81k
  • Mr. Douglas J. DevineMr. Douglas J. Devine (Age 52)
    COO & Sec.
    Comp: $1.14M
  • Mr. Mark J. Day Ph.D. (Age 51)
    Chief Technology Officer
    Comp: $718.76k
  • Mr. David A. VortMr. David A. Vort (Age 56)
    Strategic Advisor
    Comp: $896.16k
  • Mr. Daniel G. WilsonMr. Daniel G. Wilson (Age 40)
    Exec. VP of Corp. Strategy
    Comp: $670.09k
  • Mr. Brice Bobzien CPA
    Chief Financial Officer
  • Dr. Mintu P. Turakhia M.D.
    Chief Medical Officer & Chief Scientific Officer
  • Mr. Patrick Michael Murphy J.D. (Age 43)
    Chief Legal Counsel
  • Ms. Reyna M. Fernandez (Age 55)
    Exec. VP & Chief HR Officer
  • Mr. Mazi Kiani
    Sr. VP of Quality & Regulatory

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













IRTC Stock - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" IRTC shares.
View IRTC analyst ratings or view top-rated stocks.

What is iRhythm Technologies' stock price forecast for 2023?

10 analysts have issued 1-year price objectives for iRhythm Technologies' shares. Their IRTC share price forecasts range from $105.00 to $198.00. On average, they predict the company's share price to reach $158.36 in the next year. This suggests a possible upside of 42.8% from the stock's current price.
View analysts price targets for IRTC or view top-rated stocks among Wall Street analysts.

How have IRTC shares performed in 2022?

iRhythm Technologies' stock was trading at $117.69 at the beginning of 2022. Since then, IRTC shares have decreased by 5.8% and is now trading at $110.90.
View the best growth stocks for 2022 here.

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our IRTC earnings forecast.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) posted its quarterly earnings data on Tuesday, November, 1st. The company reported ($0.63) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.82) by $0.19. The business had revenue of $103.88 million for the quarter, compared to analysts' expectations of $106.43 million. iRhythm Technologies had a negative net margin of 33.79% and a negative trailing twelve-month return on equity of 39.31%.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies updated its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $407.00 million-$411.00 million, compared to the consensus revenue estimate of $418.72 million.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.23%), Sands Capital Management LLC (9.19%), BlackRock Inc. (7.49%), LTS One Management LP (4.40%), Alliancebernstein L.P. (4.34%) and Mackenzie Financial Corp (4.03%). Insiders that own company stock include Daniel G Wilson, David A Vort, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Matthew C Garrett, Merz Cathleen Noel Bairey, Quentin S Blackford, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends.

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $110.90.

How much money does iRhythm Technologies make?

iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $3.34 billion and generates $322.83 million in revenue each year. The company earns $-101,360,000.00 in net income (profit) each year or ($4.32) on an earnings per share basis.

How many employees does iRhythm Technologies have?

The company employs 1,700 workers across the globe.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com.

This page (NASDAQ:IRTC) was last updated on 12/5/2022 by MarketBeat.com Staff